News
Archive
VUV Analytics welcomes industry veteran Lou Cheng to the team
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb
VUV Analytics introduces HYDRA™: A breakthrough Vacuum Ultraviolet Detector for Liquid Chromatography
Novadip appoints Soumya Chandramouli as Chief Financial Officer
San José City Council unanimously approves next phase of San José Airport Connector Project
NorthSea Therapeutics announces publication of positive results from Phase 2b ICONA clinical trial of icosabutate in biopsy-confirmed F1-F3 MASH in Journal of Hepatology
Back To News
June 6, 2020
Ventyx Biosciences
Developing selective inhibitors of TYK2 for autoimmune diseases.